EMA Hails Success Of COVID-19 Multi-Regulator Collaboration
Executive Summary
The international COVID-19 collaborative assessment pilot, OPEN, helped regulators to reach broadly similar conclusions on vaccines and therapeutics and to avoid differences in labeling. However, most experts involved agreed there was room for improvement in some areas, particularly gaps between submissions to the different regulators.
You may also be interested in...
EU Joint Regulatory Assessment Project Bears Fruit In COVID-19
The European Medicines Agency has reported progress with a collaborative project that involves other regulators in its assessments of COVID-19 products, and with the EU Medicines for All initiative for evaluating products for non-EU markets.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.